Cargando…

Ultrarestrictive Opioid Prescription Protocol for Pain Management After Gynecologic and Abdominal Surgery

IMPORTANCE: Opioids are routinely prescribed for postoperative home pain management for most patients in the United States, with limited evidence of the amount needed to be dispensed. Opioid-based treatment often adversely affects recovery. Prescribed opioids increase the risk of chronic opioid use,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mark, Jaron, Argentieri, Deanna M., Gutierrez, Camille A., Morrell, Kayla, Eng, Kevin, Hutson, Alan D., Mayor, Paul, Szender, J. Brian, Starbuck, Kristen, Lynam, Sarah, Blum, Bonnie, Akers, Stacey, Lele, Shashikant, Paragh, Gyorgy, Odunsi, Kunle, de Leon-Casasola, Oscar, Frederick, Peter J., Zsiros, Emese
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2018
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324564/ https://www.ncbi.nlm.nih.gov/pubmed/30646274 http://dx.doi.org/10.1001/jamanetworkopen.2018.5452

Ejemplares similares

Prognostic impact of adjuvant chemotherapy treatment intensity for ovarian cancer
por: Starbuck, Kristen D., et al.
Publicado: (2018)

Evaluation of satisfaction with work–life balance among U.S. Gynecologic Oncology fellows: A cross-sectional study
por: Szender, J. Brian, et al.
Publicado: (2016)

Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study
por: Eng, Kevin H., et al.
Publicado: (2018)

Identification of Claudin 6-specific HLA class I- and HLA class II-restricted T cell receptors for cellular immunotherapy in ovarian cancer
por: Matsuzaki, Junko, et al.
Publicado: (2022)

Transmission of X-linked Ovarian Cancer: Characterization and Implications
por: Etter, John Lewis, et al.
Publicado: (2020)

Photodynamic Therapy in Gynecologic Malignancies: A Review of the Roswell Park Cancer Institute Experience
por: Mayor, Paul C., et al.
Publicado: (2016)

Estrogen Receptor-Beta2 (ERβ2)–Mutant p53–FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC)
por: Oturkar, Chetan C., et al.
Publicado: (2022)

Novel genetic variants in miR-191 gene and familial ovarian cancer
por: Shen, Jie, et al.
Publicado: (2010)

Clonality and antigen-specific responses shape the prognostic effects of tumor-infiltrating T cells in ovarian cancer
por: Tsuji, Takemasa, et al.
Publicado: (2020)

Whole‐exome sequencing of ovarian cancer families uncovers putative predisposition genes
por: Zhu, Qianqian, et al.
Publicado: (2019)

LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8(+) T cell signaling and dampen antitumor immunity in a murine ovarian cancer model
por: Huang, Ruea-Yea, et al.
Publicado: (2015)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
por: Disis, Mary L, et al.
Publicado: (2023)

Microarray Analysis Reveals Distinct Gene Expression Profiles Among Different Tumor Histology, Stage and Disease Outcomes in Endometrial Adenocarcinoma
por: Mhawech-Fauceglia, Paulette, et al.
Publicado: (2010)

Elevated Expression of the Serine-Arginine Protein Kinase 1 Gene in Ovarian Cancer and Its Role in Cisplatin Cytotoxicity In Vitro
por: Odunsi, Kunle, et al.
Publicado: (2012)

Immuno-stimultory/regulatory gene expression patterns in advanced ovarian cancer
por: Eng, Kevin H., et al.
Publicado: (2015)

Whole-Genome Sequencing Identifies PPARGC1A as a Putative Modifier of Cancer Risk in BRCA1/2 Mutation Carriers
por: Zhu, Qianqian, et al.
Publicado: (2022)

Associations between Gene Expression Variations and Ovarian Cancer Risk Alleles Identified from Genome Wide Association Studies
por: Zhao, Hua, et al.
Publicado: (2012)

Expression and Immune Responses to MAGE Antigens Predict Survival in Epithelial Ovarian Cancer
por: Daudi, Sayeema, et al.
Publicado: (2014)

BiTE secretion by adoptively transferred stem-like T cells improves FRα+ ovarian cancer control
por: McGray, A J Robert, et al.
Publicado: (2023)

Complex Segregation Analysis of Pedigrees from the Gilda Radner Familial Ovarian Cancer Registry Reveals Evidence for Mendelian Dominant Inheritance
por: Tayo, Bamidele O., et al.
Publicado: (2009)

Correction: Associations between Gene Expression Variations and Ovarian Cancer Risk Alleles Identified from Genome Wide Association Studies
por: Zhao, Hua, et al.
Publicado: (2013)

History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report
por: Minlikeeva, Albina N, et al.
Publicado: (2017)

Phyllodes Tumor of the Breast Metastasizing to the Vulva
por: Ajenifuja, Olusegun Kayode, et al.
Publicado: (2015)

Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism
por: Liao, Jianqun, et al.
Publicado: (2014)

Induction of cell death in ovarian cancer cells by doxorubicin and oncolytic vaccinia virus is associated with CREB3L1 activation
por: Mistarz, Anna, et al.
Publicado: (2021)

DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer
por: Zhang, Wa, et al.
Publicado: (2015)

Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability
por: Zhang, Wa, et al.
Publicado: (2020)

Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression
por: Agnani, Deep, et al.
Publicado: (2011)

Survival of patients with structurally-grouped TP53 mutations in ovarian and breast cancers
por: Seagle, Brandon-Luke L., et al.
Publicado: (2015)

Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia
por: Berta, Eszter, et al.
Publicado: (2022)

On representing the prognostic value of continuous gene expression biomarkers with the restricted mean survival curve
por: Eng, Kevin H., et al.
Publicado: (2015)

BRCA1 reversion mutation acquired after treatment identified by liquid biopsy
por: Mayor, Paul, et al.
Publicado: (2017)

Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia
por: Varga, Viktória E., et al.
Publicado: (2016)

Discovery of candidate tumor biomarkers for treatment with intraperitoneal chemotherapy for ovarian cancer
por: Seagle, Brandon-Luke L., et al.
Publicado: (2016)

Oncologist uptake of comprehensive genomic profile guided targeted therapy
por: Nesline, Mary K., et al.
Publicado: (2019)

Mitochondrial DNA in the tumour microenvironment activates neutrophils and is associated with worse outcomes in patients with advanced epithelial ovarian cancer
por: Singel, Kelly L., et al.
Publicado: (2018)

The Cancer Moonshot Immuno-Oncology Translational Network at 5: accelerating cancer immunotherapies
por: Annapragada, Ananth, et al.
Publicado: (2023)

PRAME expression and promoter hypomethylation in epithelial ovarian cancer
por: Zhang, Wa, et al.
Publicado: (2016)

The effects of Covid-19 mRNA vaccine on adolescence gynecological well-being
por: Mohr-Sasson, Aya, et al.
Publicado: (2023)

Reprogramming the tumor microenvironment leverages CD8(+) T cell responses to a shared tumor/self antigen in ovarian cancer
por: Mistarz, Anna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2t8mlv2o5pqo7st4n6ebh41ace